- AtriCure Names Two New Members to the Board of Directors
- AtriCure’s EPi-Sense System Approved by FDA for Treatment of Long-Standing Persistent Afib Patients
- AtriCure Reports First Quarter 2021 Financial Results
- AtriCure Names B. Kristine Johnson Board Chair
- AtriCure to Announce First Quarter 2021 Financial Results
AtriCure Inc (ATRC:NMQ) closed at 78.57, -2.32% below its 52-week high of 80.44, set on May 07, 2021.
34.04Oct 30 202080.44May 07 2021
Markit short selling activity
|Market cap||3.59bn USD|
|EPS (TTM)||-1.13 |
Data delayed at least 15 minutes, as of Jun 24 2021 21:00 BST.